Home > Items where Subject is "B Substances > Hallucinogens / Psychedelics > Mushrooms (psilocybin)"

up arrow imageUp a level
Export as
Group by: Item Type | No Grouping
Number of items at this level: 51.


O'Neill, Derek and Condron, Ita and Kelleher, Cathy and Lyons, Suzi and Mongan, Deirdre and Millar, Sean (2023) Analysis of national drug and alcohol data by regional health area. Drugnet Ireland , Issue 84, Winter 2023, insert , pp. 14-22.

Marseille, Elliot and Bertozzi, Stefano and Kahn, James G (2022) The economics of psychedelic-assisted therapies: a research agenda. Frontiers in Psychiatry , 13 .

Corrigan, Kate and Haran, Maeve and McCandliss, Conor and McManus, Roisin and Cleary, Shannon and Trant, Rebecca and Kelly, Yazeed and Ledden, Kathryn and Rush, Gavin and O'Keane, Veronica and Kelly, John R (2022) Psychedelic perceptions: mental health service user attitudes to psilocybin therapy. Irish Journal of Medical Science , 191 , (3) , pp. 1385-1397.

Edinoff, Amber N and Fort, Juliana M and Singh, Christina and Wagner, Sarah E and Rodriguez, Jessica R and Johnson, Catherine A and Cornett, Elyse M and Murnane, Kevin S and Kaye, Adam M and Kaye, Alan D (2022) Alternative options for complex, recurrent pain states using cannabinoids, psilocybin, and ketamine: a narrative review of clinical evidence. Neurology International , 14 , (2) , pp. 423-436.

Millar, Sean (2022) Drug use among students in higher education in Ireland. Drugnet Ireland , Issue 81, Spring 2022 , pp. 1-4.

Lowe, Henry and Toyang, Ngeh and Steele, Blair and Grant, Justin and Ali, Amza and Gordon, Lorenzo and Ngwa, Wilfred (2022) Psychedelics: alternative and potential therapeutic options for treating mood and anxiety disorders. Molecules , 27 , (8) , p. 2520.

Jones, Grant and Ricard, Jocelyn A and Lipson, Joshua and Nock, Matthew K (2022) Associations between classic psychedelics and opioid use disorder in a nationally-representative U.S. adult sample. Scientific Reports , 12 .

Meade, Elaine and Hehir, Sarah and Rowan, Neil and Garvey, Mary (2022) Mycotherapy: potential of fungal bioactives for the treatment of mental health disorders and morbidities of chronic pain. Journal of Fungi , 8 , (3) .

Mertens, Lea J and Koslowski, Michael and Betzler, Felix and Evens, Ricarda and Gilles, Maria and Jungaberle, Andrea and Jungaberle, Henrik and Majić, Tomislav and Ströhle, Andreas and Wolff, Max and Wellek, Stefan and Gründer, Gerhard (2022) Methodological challenges in psychedelic drug trials: efficacy and safety of psilocybin in treatment-resistant major depression (EPIsoDE) – rationale and study design. Neuroscience Applied , 1 .

Ziff, Shawn and Stern, Benjamin and Lewis, Gregory and Majeed, Maliha and Gorantla, Vasavi Rakesh (2022) Analysis of psilocybin-assisted therapy in medicine: a narrative review. Cureus , 14 , (2) .

Kopra, Emma I and Ferris, Jason A and Winstock, Adam R and Young, Allan H and Rucker, James J (2022) Adverse experiences resulting in emergency medical treatment seeking following the use of magic mushrooms. Journal of Psychopharmacology , 36 , (8) , pp. 965-973.

Bogenschutz, Michael P and Ross, Stephen and Bhatt, Snehal and Baron, Tara and Forcehimes, Alyssa A and Laska, Eugene and Mennenga, Sarah E and O'Donnell, Kelley and Owens, Lindsey T and Podrebarac, Samantha and Rotrosen, John and Tonigan, J Scott and Worth, Lindsay (2022) Percentage of heavy drinking days following psilocybin-assisted psychotherapy vs placebo in the treatment of adult patients with alcohol use disorder: a randomized clinical trial. JAMA Psychiatry , 79 , (10) , pp. 953-962.

Kuc, Joanna and Kettner, Hannes and Rosas, Fernando and Erritzoe, David and Haijen, Eline and Kaelen, Mendel and Nutt, David and Carhart-Harris, Robin L (2022) Psychedelic experience dose-dependently modulated by cannabis: results of a prospective online survey. Psychopharmacology , 239 , pp. 1425-1440.

Kelly, John R and Gillan, Claire M and Prenderville, Jack and Kelly, Clare and Harkin, Andrew and Clarke, Gerard and O'Keane, Veronica (2021) Psychedelic therapy's transdiagnostic effects: a research domain criteria (RDoC) perspective. Frontiers in Psychiatry , 12 , p. 800072.

Szigeti, Balázs and Kartner, Laura and Blemings, Allan and Rosas, Fernando and Feilding, Amanda and Nutt, David J and Carhart-Harris, Robin L and Erritzoe, David (2021) Self-blinding citizen science to explore psychedelic microdosing. eLife , 10 , e62878.

Eleftheriou, Maria Eleni and Thomas, Emily (2021) Examining the potential synergistic effects between mindfulness training and psychedelic-assisted therapy. Frontiers in Psychiatry , 12 , p. 707057.

Kelly, John R and Crockett, Matthew T and Alexander, Lauren and Haran, Maeve and Baker, Annie and Burke, Lisa and Brennan, Christine and O'Keane, Veronica (2021) Psychedelic science in post-covid psychiatry. Irish Journal of Psychological Medicine , 38 , (2) , pp. 93-98.

Bienemann, Bheatrix and Ruschel, Nina Stamato and Campos, Maria Luiza and Negreiros, Marco Aurélio and Mograbi, Daniel C (2020) Self-reported negative outcomes of psilocybin users: a quantitative textual analysis. PLoS ONE , 15 , (2 e0229067) , e0229067.

Bingham, Tim (2014) The emerald experiment. Druglink .

Cassidy, Nicola and Duggan, Edel and Tracey, Joseph A (2011) Mushroom poisoning in Ireland: the collaboration between the National Poisons Information Centre and expert mycologists. Clinical Toxicology , 49 , (3) , pp. 171-6.

Long, Jean (2010) Conference on psychoactive drugs sold in head shops and online. Drugnet Ireland , Issue 33, Spring 2010 , pp. 1-3.

Moore, Joan (2007) Drugs in Focus - policy briefing. Drugnet Ireland , Issue 22, Summer 2007 , p. 30.

Sinclair, Hamish (2006) Emerging drug trends in Europe: a case study of hallucinogenic mushrooms. Drugnet Ireland , Issue 19, Autumn 2006 , p. 19.

Moore, Joan (2006) From Drugnet Europe. Drugnet Ireland , Issue 18, Summer 2006 , p. 23.

Connolly, Johnny (2006) Government bans sale of 'magic' mushrooms. Drugnet Ireland , Issue 17, Spring 2006 , p. 9.


United Nations Office on Drugs and Crime. (2023) UN convention decisions 1961 - 2022. Vienna: United Nations Office on Drugs and Crime.

Mongan, Deirdre and Killeen, Nicki and Evans, David and Millar, Seán and Keenan, Eamon and Galvin, Brian (2022) European web survey on drugs 2021: Irish results. Dublin: Health Research Board.

O’Mahony, Desmond and McNamara, Eoin and McClintock, Rebecca and Murray, Aisling and Smyth, Emer and Watson, Dorothy (2021) Growing Up in Ireland: The lives of 20-year-olds: making the transition to adulthood. Dublin: ESRI; Trinity College Dublin; Department of Children Equality, Disability, Integration and Youth.

National Poisons Information Centre. (2021) National Poisons Information Centre annual report 2020. Dublin: National Poisons Information Centre.

Mongan, Deirdre and Millar, Seán and Galvin, Brian (2021) The 2019–20 Irish National Drug and Alcohol Survey: main findings. Dublin: Health Research Board.

Winstock, Adam R and Timmerman, C and Davies, E and Maier, LJ and Zhuparris, A and Ferris, JA and Barratt, Monica J and Kuypers, KPC (2021) Global drug survey (GDS) 2020 psychedelics key findings report. London: Global Drug Survey.

Foster, Cyrss and Scarlett, Mary and Stewart, Bill (2020) Young persons’ behaviour and attitudes survey 2019: substance use - (smoking, alcohol & drugs). Belfast: Department of Health.

Drug Enforcement Administration, U.S. Department of Justice. (2020) Drugs of abuse: a DEA resource guide. Washington DC: Drug Enforcement Administration, U.S. Department of Justice.

Rucker, James and Schnall, Jessie and D’Hotman, Daniel and King, David and Davis, Timmy and Neill, Joanna (2020) Medicinal use of psilocybin: Reducing restrictions on research and treatment. London: Conservative Drug Policy Reform Group.

Laboratory and Scientific Section, United Nations Office on Drugs and Crime. (2013) The challenge of new psychoactive substances. A report from the Global SMART Programme. Vienna: United Nations Office on Drugs and Crime.

Centre for Public Health, Liverpool John Moores University. (2011) A summary of the health harms of drugs. London: Department of Health & National Treatment Agency for Substance Misuse.

European Monitoring Centre for Drugs and Drug Addiction. (2006) Hallucinogenic mushrooms. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

Dail Debates

[Oireachtas] Dáil Éireann debate. Questions 162 - Research and development [26461/23]. (31 May 2023)

[Oireachtas] Dail Eireann debate. Written answers 456, 477 & 478 - proposed legislation [Psilocybin & headshops] [23891/12]. (15 May 2012)

[Oireachtas] Dail Eireann debate. Written answer 125 - National drugs strategy [Magic mushrooms] [21015/10]. (19 May 2010)

[Oireachtas] Dail Eireann debate. Written answer 74 - National Drugs Strategy [Head shops] [39804/09]. (05 Nov 2009)

[Oireachtas] Dail Eireann debate. Written answer 144 - Legislative programme [Hallucinogenic substances] [26827/06]. (05 Jul 2006)


Shapiro, Harry (2010) The media guide to drugs: key facts and figures for journalists. London: Drugscope .

Conference or Workshop Item

Garcia-Romeu, Albert (2017) Psychedelics as change agents in addiction and mood disorders. In: Society for the Study of Addictions annual conference 2017, 10 November 2017, Newcastle Upon Tyne.


Hall, Wayne (2022) NDARC webinar series presentation. Implications of the revival of therapeutic research on psychedelic drugs. National Drug and Alcohol Research Centre.


Health Research Board. (2021) National Drug and Alcohol Survey [Ireland].


[Irish Times] , Lally, Conor Dublin trial assesses use of magic mushrooms on those with depression. (29 Aug 2020)

[Independent.ie] , Foy, Ken and Feehan, Conor Gardai uncover first ever 'magic mushroom lab' in Ireland following raid. (12 Jul 2018)

Associated Press. [thejournal.ie] 'It really changed everything for me': How magic mushrooms helped treat anxiety in cancer patients. (04 Dec 2016)

[Irish Examiner] , Moore, Ollie Irish scientists leading street drug research. (30 Apr 2013)

[rte.ie] Sale and use of magic mushrooms banned. (31 Jan 2006)

This list was generated on Fri Apr 19 04:34:29 2024 IST.